A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin's lymphoma.

Pierre Soubeyran; Amine Masmoudi; Christelle Blanc-Bisson; Nathalie Quénel; Bernard Hoerni; Ricardo Bellott; Jacques Robert; Isabelle Soubeyran; Catherine Donamaria; Matthieu Molimard

doi:10.1016/j.ejca.2005.11.044

A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin's lymphoma.

Identifier:nobleid.org/w1/20260515/D99A2CD2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D99A2CD2.svg?ark=w1%2F20260515%2FD99A2CD2)](https://nobleid.org/work/w1/20260515/D99A2CD2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Pierre Soubeyran

Amine Masmoudi

Christelle Blanc-Bisson

Claim authorship of this work

A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin's lymphoma.

Identifier:nobleid.org/w1/20260515/D99A2CD2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D99A2CD2.svg?ark=w1%2F20260515%2FD99A2CD2)](https://nobleid.org/work/w1/20260515/D99A2CD2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Pierre Soubeyran

Amine Masmoudi

Christelle Blanc-Bisson

Claim authorship of this work